Elevated CDK5 and its kinase activity have been reported in different types of cancers including breast cancer, lung cancer, liver cancer, pancreatic cancer, thyroid carcinoma, and myeloma [9, 13–16]. This evidence concerns the gene CDK5 and plasma cell myeloma.